Press release

Indena & dsm-firmenich pioneer a new “age of nature” through selected market-inspired botanical solutions for human health

Kaiseraugst (Switzerland), Milan (Italy) - October 25, 2023

Indena, a private Italian company with a century of experience in the identification, development and production of high-quality, innovative and effective active botanical principles for the pharmaceutical and health food industries, and dsm-firmenich, innovators in nutrition, health and beauty, have announced a strategic partnership in some specific areas. The collaboration will pioneer the development of novel scientific evidence to support the effectiveness of natural solutions in the human health arena, leveraging both companies' values, visions and knowledge. It is poised to inspire a new ‘Age of Nature’, which will contribute to drive the future of nutraceuticals.


With promising research on the positive benefits of botanicals, the partnership is dedicated to specific health areas and selected ingredients, including those to support immunity, vision, brain health, women's health, healthy aging and gut health. Through this science-based approach, dsm-firmenich and Indena aim to lead innovation in the global nutritional botanical market to deliver advanced solutions that resonate with the needs of today’s consumers.

This cooperation will bring highly effective Market-ready Solutions to the market, as well as, in the medium- and long-term, products that will be new in terms of their origin, ingredient combination and formulation.

“This partnership has come about from a vision shared by Indena and dsm-firmenich: to identify and develop innovative solutions for human health, combining a deeply-rooted scientific background with the visionary capacity to imagine the future challenges of nutraceuticals,” states Daniele Giavini, Managing Director at Indena. “Today’s savvy consumer requires increasingly smarter products in terms of ingredients as well as formulation. Already in the next few months, our collaboration will bring products onto the market that combine and enhance the effectiveness of technologically advanced botanical extracts and ingredients from both companies. But above all, we want to launch a medium- and long-term planning process to build solutions that are not yet existing: solutions devised to respond to the increasingly sophisticated demands of a public wishing to take care of their own wellbeing with products that are scientifically studied, clinically tested and technologically ground-breaking, for proven effectiveness.”

“As consumer demand for botanicals continues to gain traction globally, this purpose-led partnership directly addresses the market need for effective, science-backed products that are aligned to the most relevant health needs,” comments Martin Dos Ramos, Global Vice President Dietary Supplements at dsm-firmenich. “Indena has long been a pioneer in the research and development of botanical derivatives. Science will remain at the core of our partnership and, when combined with our premix and market-ready solutions, flavor, taste masking and product formulation expertise, we are ideally placed to help take our customers’ innovations to the next level.”

Both companies are committed to driving progress towards the UN’s Sustainable Development Goals. All projects within the strategic partnership aim to put sustainability first – from raw materials sourcing to production and marketing – with a focus on environmental impact, use of renewable energies and building a more circular economy.

For all business areas, other than the solutions selected for the partnership, the two companies will proceed fully independently.

The partnership announcement between dsm-firmenich and Indena marks day one of SupplySide West, which takes place in Las Vegas from 25 to 26 October 2023.

About Indena

Indena is the leading company dedicated to the identification, development and production of high-quality active principles derived from plants, for use in the pharmaceutical and health food industries. Backed up by a century of botanical experience, the company owns 100 patent families, has published more than 1,000 scientific studies and co- operates with the world’s most prestigious universities and private research institutions. Indena employs over 900 staff, investing a significant amount of its annual turnover in research, making this activity the key to its success. Headquartered in Milan, Indena has 4 production sites and 5 international branches throughout the world and manages sales in more than 80 countries. The company's experts communicate and interact constantly with the major international regulatory authorities and cooperate on the update of all the main pharmacopoeias. Find more on

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.

For more information



Contact e-mail




Issuing agency e-mail


Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.